Streamlining the Validation of Patient Reported Outcome (PRO) Measures in Drug Regulatory Processes.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 5, p. 255, doi. 10.1007/s40290-015-0110-x
- By:
- Publication type:
- Article
Works matching IS 11782595 AND DT 2015 AND VI 29 AND IP 5
Results: 7
1
2
The European College of Neuropsychopharmacology (ECNP) Medicines Chest Initiative: Rationale and Promise.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 5, p. 269, doi. 10.1007/s40290-015-0111-9
- By:
- Publication type:
- Article
3
Improving Health Care Decision Making in the USA Through Comparative Effectiveness Research: The Role of Economic Evaluation.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 5, p. 247, doi. 10.1007/s40290-015-0113-7
- By:
- Publication type:
- Article
4
Forum.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 5, p. 297, doi. 10.1007/s40290-015-0114-6
- Publication type:
- Article
5
Major Pharmaceutical Conferences and Courses.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 5, p. 309, doi. 10.1007/s40290-015-0115-5
- Publication type:
- Article
6
Drugs in Clinical Development for Chronic Lymphocytic Leukaemia: Summary and Table.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 5, p. 285, doi. 10.1007/s40290-015-0118-2
- Publication type:
- Article
7
Causality Assessment of Possible Adverse Drug Reactions in Clinical Trials: An Analysis of Factors Associated with Decision Making by Clinical Investigators in Japan.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 5, p. 275, doi. 10.1007/s40290-015-0109-3
- By:
- Publication type:
- Article